FDA.reportPublic FDA data

ETHYLCELLULOSE (7 MPA.S)

Substance profile for UNII H3UP11403C, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
H3UP11403C
Preferred term
ETHYLCELLULOSE (7 MPA.S)
Registry number
9004-57-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1312575
PubChem
0
NCIt
C83703
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1312575mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1312575
NCI ThesaurusC83703ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C83703
FDA Substance Registration SystemH3UP11403Cprecision.fda.gov/uniisearch/srs/unii/H3UP11403C

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only7
Amantadine Hydrochloride Capsules, USP1
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only1
Amantadine Hydrochloride Capsules, USP5
Amantadine Hydrochloride Capsules, USP1
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only1
VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only6
Amantadine Hydrochloride Capsules, USP1
These highlights do not include all the information needed to use levetiracetam extended-release tablets safely and effectively. See full prescribing information for levetiracetam extended-release tablets. LEVETIRACETAM extended-release tablets for oral use Initial U.S. Approval: 19991
METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 500 mg and 750 mg 7267 7212 Rx only1
Amantadine Hydrochloride Capsules, USP1
METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 500 mg and 750 mg 7267 7212 Rx only1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
TOPIRAMATE CAPSULE, COATED PELLETS [TEVA PHARMACEUTICALS USA INC]14
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]13
AMANTADINE HYDROCHLORIDE CAPSULE [SANDOZ INC]12
AMANTADINE HYDROCHLORIDE CAPSULE [UPSHER-SMITH LABORATORIES, INC.]10
CLARITHROMYCIN TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]8
LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]4
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]4
CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [APOTEX CORP.]3
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]3
AMANTADINE HYDROCHLORIDE CAPSULE [AMERICAN HEALTH PACKAGING]2
AMANTADINE HYDROCHLORIDE CAPSULE [CARILION MATERIALS MANAGEMENT]2
AMANTADINE HYDROCHLORIDE CAPSULE [MYLAN INSTITUTIONAL INC.]2
TOPIRAMATE CAPSULE, COATED PELLETS [AMERICAN HEALTH PACKAGING]2
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [AVKARE, INC.]2
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK]2
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]2
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PROFICIENT RX LP]2
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PROFICIENT RX LP]2
AMANTADINE HYDROCHLORIDE CAPSULE [A-S MEDICATION SOLUTIONS LLC]1
AMANTADINE HYDROCHLORIDE CAPSULE [A-S MEDICATION SOLUTIONS LLC]1
AMANTADINE HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [PROFICIENT RX LP]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]1
VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REMEDYREPACK INC. ]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII H3UP11403C page 1 of 1 ยท 7 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573CAPSULEORAL62.13 mg
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573CAPSULE, DELAYED RELEASEORAL1092 mg
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573CAPSULE, EXTENDED RELEASEORAL177 mg
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573TABLETORAL1133 mg
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573TABLET, DELAYED RELEASEORAL15 mg
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573TABLET, EXTENDED RELEASEORAL81 mg
ETHYLCELLULOSE (7 MPA.S)H3UP11403C9004573TABLET, ORALLY DISINTEGRATINGORAL140 mg